直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Tesla’s Preservation of District Court Indefiniteness Positions Creates IPR Roadblock

November 18, 2025

Authored and Edited by Prince M. Ene, Pharm. D.; Umber Aggarwal; Forrest A. Jones

In Tesla, Inc. v. Intellectual Ventures II LLC, No. IPR2025-00340, Paper 18 (Director, Nov. 5, 2025) (informative), Director Squires issued a director review order reversing an initial decision granting institution because the Petitioner argued in district court litigation a claim term was indefinite, but in the IPR contended “no claim term requires express construction” and applied the “plain and ordinary meaning.” The Director found these were inconsistent constructions, and de-instituted because the Petitioner failed to provide a sufficient explanation to assert different positions. Notably, this decision was marked informative. 

This decision came after Tesla survived the USPTO’s stricter discretionary denial rules due to (i) Tesla agreeing to a broader Sotera stipulation, (ii) three previous Board decisions instituting similar claims, and (iii) the patent being involved in a highly complex litigation involving 11 patents spanning nine different families, as we previously discussed in a previous post.[1][A1] 

In seeking director review of the institution decision, Intellectual Ventures argued that the Board should have discretionarily denied the petition because Tesla advanced inconsistent claim construction positions for the same claim term in the IPR and a parallel district court case. The Director agreed, focusing on two positions Tesla took for the claim limitation “generating said target feature information from said data statistics”:

  1. In District Court, Tesla argued the limitation was indefinite because a person of ordinary skill in the art could not determine its meaning and scope with reasonable certainty.
  2. At the PTAB, Tesla argued that “no claim term requires express construction” and adopted the Patent Owner's “plain and ordinary meaning” construction from the district court litigation.

The Director acknowledged the rules do not “prohibit [P]etitioners from taking inconsistent claim construction positions,” but the Petitioner is required to explain why those different positions are warranted. Tesla’s only explanation noted the “statutory[] prohibit[ion] [on] raising indefiniteness challenges in an inter partes review.” The Director, however, found this insufficient, stating it “amounts to an assertion that a Petitioner should be permitted to raise inconsistent invalidity challenges in [] two forums.”

The Director explained what a sufficient argument might have looked like:

Petitioner’s explanation may have risen to a sufficient level, for example, if Petitioner had shown that, notwithstanding the alleged indefiniteness of the claim term, an ordinarily skilled artisan would understand that the asserted art satisfies the claim limitation (such as if the limitation prescribed a range and only the outer bounds of the range were unclear). 

Because Tesla failed to provide this level of detail or another sufficient explanation, the Director found that its approach “detracts from, the Office’s goal of ‘providing greater predictability and certainty in the patent system.’” Accordingly, the Director granted director review, vacated the institution decision, and discretionarily denied the petition.

Petitioners should be cautious when asserting different claim construction positions in the district court and at the Board, even when they are statutorily barred from raising a position at the PTAB, such as where a claim term is indefinite. If facially inconsistent positions are taken, Petitioners should sufficiently explain why different positions are warranted in different forums. In preparing discretionary denial arguments, Patent Owners should review whether Petitioners have presented claim construction positions before the Board that differ from those taken in other forums.


Endnotes

[1] On July 2, 2025, Acting Director Stewart denied Intellectual Ventures’ discretionary denial request and referred IPR2025-00340 to the Board for the same reasons as those discussed in Tesla, Inc. v. Intellectual Ventures II LLC, IPR025-00217, Paper 9 (Director June 13, 2025). The hyperlinked blog post discusses reasons why the IPR025-00217 petition was referred. 

Tags

United States Patent and Trademark Office (USPTO), discretionary denials

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Offices

Washington, DC

Contacts

Prince M. Ene, Pharm. D.
Associate
Washington, DC
+1 202 408 4036
Email
Umber Aggarwal
Associate
Reston, VA
+1 571 203 2423
Email
Forrest A. Jones
Partner
Washington, DC
+1 202 408 4019
Email

Copyright © 2025 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP